folsom_lives
pretty_lil_dirt_boi
No love for The Flying Spaghetti Monster?I would start thanking Baphomet and Allah. The funny part is I'm buddhist but I do love to stir the shit up.
No love for The Flying Spaghetti Monster?I would start thanking Baphomet and Allah. The funny part is I'm buddhist but I do love to stir the shit up.
It wouldn't really get the point across to anyone thanking Jesus for a steady rate of 3000 deaths.No love for The Flying Spaghetti Monster?
sameI would start thanking Baphomet and Allah. The funny part is I'm buddhist but I do love to stir the shit up.
At least some good news
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study
Pfizer Inc (PFE.N) and BioNTech's COVID-19 vaccine appears able to protect against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the U.S. drugmaker.www.reuters.com
It's not a waste, as it is shown to be over 80% effective with a single dose, which is better than many other vaccines' efficacy. The more we get ahead of the South African strain and others like it the better.Someone please talk sense to me, this seems REALLY REALLY DUMB! So instead of saving some people we’re gonna just waste all of those efforts so that we can give a shit ton of other people a half dose without a guarantee of receiving their full dose?
Exclusive: Biden will release nearly all available vaccine doses in break from Trump administration policy of holding back stock for second dose
President-elect Joe Biden will aim to release nearly every available dose of the coronavirus vaccine when he takes office, a break with the Trump administration's strategy of holding back half of US vaccine production to ensure second doses are available.www.cnn.com
Also production for that vaccine seems to be ramped up with new facilities opening up, so chances are good that enough doses are available for the second shot.but it is a riskIt's not a waste, as it is shown to be over 80% effective with a single dose, which is better than many other vaccines' efficacy. The more we get ahead of the South African strain and others like it the better.
Honestly, I think the point is moot anyway though, since our ability to deliver them currently faaaaaar outpaces our ability to administer them, so we need to solve that problem first.
Wooooow, don't have a heart attack in LA.
Hospitals in California, which are already at maximum capacity, have begun seeing patients in gift shops, parking lots and outdoor tents. Ambulances are being forced to queue outside of hospitals for hours as they wait for Emergency Room workers to take their patients.
Dr Marianne Gausche-Hill, the medical director of LA County's Emergency Services Agency who issued the latest directives, told CBS News that ambulance workers will continue to work to save lives of patients at the scene.
"We are not abandoning resuscitation," Dr Gausche-Hill said. "We are absolutely doing best practice resuscitation and that is do it in the field, do it right away."
"What we're asking is that - which is slightly different than before - is that we are emphasising the fact that transporting these patients arrested leads to very poor outcomes," she added. "We knew that already and we just don't want to impact our hospitals."
Treating heart attack and stroke patients at the scene can increase chances of survival, she said.
Covid: LA ambulances told not to transport some patients to hospital
LA County is experiencing one of the worst US Covid outbreaks, with hospital supplies running low.www.bbc.com
Where does this 80% come from, has it been studied? It took a control some 14,000 strong to come up with the 95% number and maybe I’m wrong but I haven’t read anything but speculation about the 80%It's not a waste, as it is shown to be over 80% effective with a single dose, which is better than many other vaccines' efficacy. The more we get ahead of the South African strain and others like it the better.
Honestly, I think the point is moot anyway though, since our ability to deliver them currently faaaaaar outpaces our ability to administer them, so we need to solve that problem first.
It's been a while since I looked into that. It is a rough number that I read from some scientists evaluating the data. You are right that the results publicized by Pfizer doesn't specifically look at that. They published that it is 52% effective after the first does, but this seems to include the time immediately after the first dose, while it seems to take a week or two to really become effective, so the 80% came from people looking at the incidence curve after that first or second week.Where does this 80% come from, has it been studied? It took a control some 14,000 strong to come up with the 95% number and maybe I’m wrong but I haven’t read anything but speculation about the 80%
How effective is just one dose?
A paper published in the New England Journal of Medicine stated that the efficacy of the Pfizer-BioNTech vaccine was 52.4% between the first and second dose (spaced 21 days apart).5 However, in its “green book” Public Health England said that during the phase III trial most of the vaccine failures were in the days immediately after the first dose, indicating that the short term protection starts around day 10.6 Looking at the data from day 15 to 21, it calculated that the efficacy against symptomatic covid-19 was around 89% (95% confidence interval 52% to 97%). Meanwhile, Pfizer has said that it has no evidence that the protection lasts beyond the 21 days.
In the case of the Oxford-AstraZeneca vaccine, PHE said, “High protection against hospitalisation was seen from 21 days after dose one until two weeks after the second dose, suggesting that a single dose will provide high short term protection against severe disease . . . An exploratory analysis of participants who had received one standard dose of the vaccine suggested that efficacy against symptomatic covid-19 was 73% (95% CI 48.79-85.76%).”
I’m always one that’s eager and willing to trust the science. But I just don’t see the science here at all. You have data showing the efficacy of two doses and no data showing the efficacy of one dose. Not only that but where does this put citizens trust and comfortably with the vaccine in general? I would think it foolish for somebody to not get the vaccine that’s proven to have 95% efficacy and very understandable for somebody to not want to get it if they know the efficacy of this brand new worlds fastest vaccine may only be 50%, may only be 20% .... who knows! There’s no precedent. So what this sounds like is it’s just going to be the worlds largest ever vaccine trial.Here is some more info:
Covid-19 vaccination: What’s the evidence for extending the dosing interval?
I found a paper yesterday that seemed to suggest that even using the 52%, it may save more lives to vaccinate twice as many people at that rate, but am having trouble finding it today.
Edit: to be clear, I'm not trying to argue that it is definitely a good idea to do single dose, but what I have seen makes me think it is certainly worth the experts considering it. Also, I will again stress that we (the USA) seem to have a very long way to go in speeding up the administering of the vaccines before this is even possibly beneficial IF it is decided it is a great idea.
I'm not sure how you get that there is "no data showing the efficacy of one dose" from what I quoted.I’m always one that’s eager and willing to trust the science. But I just don’t see the science here at all. You have data showing the efficacy of two doses and no data showing the efficacy of one dose. Not only that but where does this put citizens trust and comfortably with the virus in general? I would think it foolish for somebody to not get the vaccine that’s proven to have 95% efficacy and very understandable for somebody to not want to get it if they know the efficacy of this brand new worlds fastest vaccine may only be 50%, may only be 20% .... who knows! There’s no precedent. So what this sounds like is it’s just going to be the worlds largest ever vaccine trial.
So you posted an article that I read. In the article it describes “There isn’t much for the Pfizer-BioNTech vaccine, as trials did not compare different dose spacing or compare one with two doses.” With the AstaZeneca vaccine they did space it out but the amount of participants was much lower and of course that’s a different vaccine, and it wouldn’t be fair to assume that all efficacy of the mRNA tech will have the same immune responses, otherwise why not mix and match your first does Pfizer with a second dose of something else. The article, in my interpretation, just reiterates that there is in fact no basis for making this decision. You’re essentially dialing back the clock and turning a fast track approved phase 3 vaccine into the non-approved phase 3 trial. The parameters are entirely different. They authorized this EUA for two doses, not one.I'm not sure how you get that there is "no data showing the efficacy of one dose" from what I quoted.
All I have said is that there is data that suggests it is worth considering. The only thing I disagree with that you have said is that there is "no data." I guess you mean there isn't a completed study to evaluate the long term efficacy of a single dose, which is true and obviously would put the debate to rest if/when done.So you posted an article that I read. In the article it describes “There isn’t much for the Pfizer-BioNTech vaccine, as trials did not compare different dose spacing or compare one with two doses.” With the AstaZeneca vaccine they did space it out but the amount of participants was much lower and of course that’s a different vaccine, and it wouldn’t be fair to assume that all efficacy of the mRNA tech will have the same immune responses, otherwise why not mix and match your first does Pfizer with a second dose of something else. The article, in my interpretation, just reiterates that there is in fact no basis for making this decision. You’re essentially dialing back the clock and turning a fast track approved phase 3 vaccine into the non-approved phase 3 trial. The parameters are entirely different. They authorized this EUA for two doses, not one.
I completely understand your stance, and wish I could find this optimism as well. But I simply can’t get behind this, nothing personal at all.